RediNews
ETFs Holding STML »    STML Historical Stock Prices »
STML News Video: Mon, May 20, 2019, 3:43 PM — Daily Dividend Report: WLK, CABO, MORN, AAON, FMBI


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Stemline Therapeutics is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing oncology therapeutics. Co. is developing three clinical stage product candidates: SL-401, SL-801, and SL-701. SL-401 is a targeted therapy directed to the interleukin-3 receptor, which exists on a range of malignancies and is being assessed in clinical trials of other indications including myelomonocytic leukemia and myelofibrosis and multiple myeloma. SL-801 is an oral, small molecule, reversible inhibitor of Exportin-1, a nuclear transport protein implicated in a range of malignancies. SL-701 is an immunotherapy designed to direct the immune system to attack brain cancer. Self directed investors in Stemline Therapeutics Inc will be interested in keeping up with all Stemline Therapeutics Inc news they can find, both STML news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on STML. At RediNews, we simplify this task by presenting both STML news releases originating from Stemline Therapeutics Inc itself, and STML news from a variety of media outlets. Visitors can browse this news online and through our STML RSS news feed.

STML News

STML News — Articles, Videos, & Press Releases

Analysts Anticipate XBI Will Reach $129
Thursday, May 2, 2019, 8:23 AM — ETF Channel
Stemline Therapeutics Stock Sees Short Interest Expand By 12%
Wednesday, April 10, 2019, 12:23 PM — Market News Video
Stemline Therapeutics (STML) Shares Cross Above 200 DMA
Wednesday, April 3, 2019, 4:41 PM — Market News Video
The Implied Analyst 12-Month Target For PXSG
Wednesday, March 27, 2019, 7:39 AM — ETF Channel
First Week of STML May 17th Options Trading
Thursday, March 21, 2019, 10:54 AM — Stock Options Channel
Stemline Therapeutics Stock Sees Short Interest Move 16.3% Higher
Thursday, February 28, 2019, 11:41 AM — Market News Video
Analysts Anticipate PXSG Will Reach $45
Wednesday, February 20, 2019, 9:29 AM — ETF Channel
Analysts Expect 35% Upside For The Holdings of PXSG
Thursday, January 17, 2019, 9:05 AM — ETF Channel
Commit To Buy Stemline Therapeutics At $7.50, Earn 16.6% Annualized Using Options
Thursday, December 27, 2018, 11:09 AM — Stock Options Channel
Implied IWO Analyst Target Price: $239
Wednesday, December 12, 2018, 8:12 AM — ETF Channel
Notable Monday Option Activity: STLD, STML, SPWR
Monday, November 26, 2018, 3:16 PM — Stock Options Channel
Relative Strength Alert For Stemline Therapeutics
Friday, November 9, 2018, 1:09 PM — Dividend Channel
Look Under The Hood: PXSG Has 31% Upside
Friday, November 9, 2018, 7:24 AM — ETF Channel
Oversold Conditions For Stemline Therapeutics (STML)
Monday, October 15, 2018, 11:57 AM — Dividend Channel
Look Under The Hood: XBI Has 51% Upside
Friday, October 5, 2018, 8:03 AM — ETF Channel
Commit To Purchase Stemline Therapeutics At $12.50, Earn 13% Annualized Using Options
Friday, September 28, 2018, 11:49 AM — Stock Options Channel
STML Crosses Below Key Moving Average Level
Wednesday, September 26, 2018, 5:01 PM — Market News Video
Analysts Anticipate PXSG To Hit $46
Friday, August 31, 2018, 9:26 AM — ETF Channel
STML Makes Bullish Cross Above Critical Moving Average
Tuesday, August 14, 2018, 11:34 AM — Market News Video
Short Interest In Stemline Therapeutics Declines 19.4%
Friday, August 10, 2018, 12:27 PM — Market News Video
Analysts Predict 10% Upside For DWAS
Monday, July 30, 2018, 8:28 AM — ETF Channel
Stemline Therapeutics Becomes Oversold (STML)
Monday, July 16, 2018, 11:52 AM — Dividend Channel
Add Up The Pieces: IEIH Could Be Worth $30
Thursday, June 28, 2018, 8:31 AM — ETF Channel
Stemline Therapeutics is Now Oversold (STML)
Friday, June 22, 2018, 5:18 PM — Dividend Channel
Short Interest Drops 17% For STML
Friday, May 25, 2018, 2:09 PM — Market News Video
Analysts Forecast 22% Upside For The Holdings of IEIH
Friday, May 25, 2018, 8:04 AM — ETF Channel
STML is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

PPHM News
ARWR News
PSDV News
CHTP News
GALE News
BLUE News
NBS News
BIND News
NXTM News
PATH News

RediNews invites you to check out our oh so simple RSS feeds. You don't have to be the webmaster of an investor relations website, integrating investor relations components through an enterprise portal, to work with RSS. Even if you've never worked with a feed for a stock quote for website pages, from a stock market content provider, you can pick up an RSS feed. RSS is not a custom stock feed for website pages, there is nothing custom about it. Rather than custom web content delivered via non-standard XML, our RSS feeds are based on the Really Simple Syndication protocol. To give our feeds a try, look for the RSS icon for any news page (which will look like this): . The feeds can be requested on a symbol by symbol basis, so ideally our news could go on a stock quote page by symbol, or on a broader market page next to a free index chart or index table of the market averages, especially our sector by sector feeds which update intraday on a live basis as new news is added to our database. So whether it is a list of recent news next to an intraday chart, an end of day summary of the markets with all of the most recent news, or a list of the market makers for a given stock, our news can fit in well with the other stock market content your website features.

STML News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.